StonvexLoading…
StonvexStonvexStonvexCore line items from OCUL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $51.95M | $63.72M | $58.44M | $51.49M |
Operating Income | $-270.02M | $-171.78M | $-82.38M | $-78.65M |
Net Income | $-265.94M | $-193.51M | $-80.74M | $-71.04M |
EPS (Diluted) | $-1.42 | $-1.22 | $-1.02 | $-0.97 |
Total Assets | $808.06M | $457.94M | $252.06M | $149.29M |
Total Liabilities | $153.75M | $142.59M | $160.93M | $113.91M |
Cash & Equivalents | $737.06M | $392.10M | $195.81M | $102.30M |
Free Cash Flow OCF − CapEx | $-216.89M | $-135.97M | $-76.32M | $-63.32M |
Shares Outstanding | 215.93M | 157.75M | 114.96M | 77.20M |